Pedro Navarro Amador

I’m Pedro — a results-driven Healthcare Tender Specialist at Eductrade, blending strategic insight with persuasive communication to win competitive bids and deliver impactful healthcare projects. I excel at crafting high-impact, tailored proposals that resonate with stakeholders, while forging strong, trust-based relationships across international markets. With a proven record in bid management, supplier negotiations, and securing favorable contract terms, I thrive in high-stakes environments where precision, speed, and influence are key. Passionate about transforming complex healthcare needs into innovative, sustainable solutions, I bring both the drive and the vision to turn opportunities into lasting success.

Presented two research papers/abstracts as a co-author at both national and international conferences.

• Juan Luis López-Cánovas1, María Castejón-Mariscal de Gante1, Beatriz Naranjo1, Pedro Navarro1, Alberto Diaz-Ruiz1. Cell plasticity of liver cancer cells is blunted by fasting in combination with the cocktail Metformin-Sorafenib. Conference “Time for the liver chronobiology, aging, and current matters in hepatology” 26-27 Enero 2023. Bochum, Germany. (P)
• Juan Luis López-Cánovas1, María Castejón-Mariscal de Gante1, Beatriz Naranjo1, Pedro Navarro1, Alberto Diaz-Ruiz1. “La restricción calórica potencia el efecto sinérgico del cóctel sorafenib-metformina en cáncer de hígado”. 48º Congreso Anual AEEH Madrid 15-17 Marzo 2023.